Takeda: all 1,753 studies

Page 7 of 18. Open to participants first (93), then studies with results posted, then the rest; newest registration first within each.

• Bioavailability and Pharmacokinetics of Vedolizumab in Healthy Participants Following Single Subcutaneous AdministrationCompletedNCT02163421Phase 1Results posted
• Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency AblationTerminatedNCT02162758Phase 2Results posted
• Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second VaccinationCompletedNCT02158364Results posted
• Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"CompletedNCT02154139Results posted
• Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in ChildrenCompletedNCT02153112Phase 2Results posted
• Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of ENV8058 (TAK-058) in Healthy ParticipantsCompletedNCT02153099Phase 1Results posted
• Ramelteon 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Accompanied by Difficulty Falling Asleep> - Transitional Survey From the Preceding Drug-use Survey -CompletedNCT02153086Results posted
• Evaluation of the Safety and Efficacy of Long-term Use of Omega-3 Fatty Acid Ethyl EstersCompletedNCT02153073Results posted
• Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]CompletedNCT02151786Results posted
• Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First VaccinationCompletedNCT02151773Results posted
• Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy AdultsCompletedNCT02142504Phase 2Results posted
• A Study of TAK-385 in Hormone Treatment-naïve Participants With Prostate CancerCompletedNCT02141659Phase 1Results posted
• Brentuximab Vedotin (Recombinant) for IV Infusion - Special Drug Use Surveillance (All-case Surveillance) "Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma"CompletedNCT02139592Results posted
• Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With GoutCompletedNCT02139046Phase 3Results posted
• Safety and Efficacy of TAK-385 for Patients With Localized Prostate CancerCompletedNCT02135445Phase 2Results posted
• Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"CompletedNCT02134977Results posted
• Efficacy and Safety of Namilumab (MT203) for Plaque PsoriasisCompletedNCT02129777Phase 2Results posted
• Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal ImpairmentCompletedNCT02128490Phase 2Results posted
• Taste Assessment Study of SHP429 in Healthy Adult SubjectsCompletedNCT02125292Phase 1Results posted
• Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid TumorsCompletedNCT02122770Phase 1Results posted
• A Phase 1/2 Study of a Intramuscular Injection of TAK-850 in Healthy Adult SubjectsCompletedNCT02111252Phase 1/2Results posted
• Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance -CompletedNCT02106455Results posted
• 36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg TabletsCompletedNCT02106442Results posted
• Azilsaltan Tablets (Azilva Tablets) Special Drug Use Surveillance "Hypertension Complicated by Diabetes "CompletedNCT02100319Results posted
• Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory DrugsCompletedNCT02099708Results posted
• Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose AspirinCompletedNCT02099682Results posted
• Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to PioglitazoneCompletedNCT02098746Results posted
• Long-term Use of Sonias Combination Tablets in Patients With Type 2 Diabetes MellitusCompletedNCT02098733Results posted
• Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating TabletsCompletedNCT02096458Phase 1Results posted
• A Study to Evaluate the Efficacy of Brigatinib (AP26113) in Participants With Anaplastic Lymphoma Kinase (ALK)-Positive, Non-small Cell Lung Cancer (NSCLC) Previously Treated With CrizotinibCompletedNCT02094573Phase 2Results posted
• A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema ParticipantsCompletedNCT02093923Phase 1Results posted
• Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative ColitisCompletedNCT02093663Phase 3Results posted
• A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy SubjectsCompletedNCT02093390Phase 1Results posted
• Azilsartan Tablets Special Drug Use Surveillance: Long-term UseCompletedNCT02092025Results posted
• Special Drug Use Surveillance on Long-term Use of Sodium Risedronate Tablets (Benet 75 mg Tablets) (12-month Treatment Survey)CompletedNCT02089997Results posted
• Panitumumab for Intravenous Infusion 100 mg and 400 mg Special Drug Use Surveillance "Survey on Unresectable, Advanced or Recurrent Colorectal Cancer With Wild-type KRAS Gene" (All-patient Surveillance)CompletedNCT02089737Results posted
• A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate CancerCompletedNCT02085252Phase 3Results posted
• A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate CancerCompletedNCT02083185Phase 2Results posted
• Roflumilast Plus Antipsychotics Proof of Mechanism Study in SchizophreniaCompletedNCT02079844Phase 1Results posted
• A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-RCompletedNCT02079805Phase 4Results posted
• Phase III Study of Intramuscular TAK-816 in Healthy InfantsCompletedNCT02074345Phase 3Results posted
• Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Insulin Products / Long-term Treatment"CompletedNCT02068508Results posted
• Candesartan Cilexetil/Amlodipine Besilate Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"CompletedNCT02068495Results posted
• Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise TherapyCompletedNCT02068443Phase 3Results posted
• Bioavailability, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets in Healthy ParticipantsCompletedNCT02064907Phase 1Results posted
• A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 TabletsCompletedNCT02063854Phase 2/3Results posted
• Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA DiseaseCompletedNCT02060526Phase 2Results posted
• Ramelteon Tablets 8mg Drug Use Surveillance: Survey on Insomnia Associated With Sleep-onset DifficultyCompletedNCT02058992Results posted
• Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive ImpairmentCompletedNCT02055118Phase 2/3Results posted
• Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary AngioedemaCompletedNCT02052141Phase 3Results posted
• Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 DiabetesCompletedNCT02049814Phase 4Results posted
• Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple MyelomaCompletedNCT02046070Phase 2Results posted
• Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese VolunteersCompletedNCT02045264Phase 1Results posted
• A Dose Escalation Study of MLN7243 (TAK-243) in Adult Participants With Advanced Solid TumorsTerminatedNCT02045095Phase 1Results posted
• Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative ColitisCompletedNCT02039505Phase 3Results posted
• Phase III Study of MLN0002 (300 mg) in Treatment of Crohn's DiseaseCompletedNCT02038920Phase 3Results posted
• Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP VaccineCompletedNCT02038907Phase 2Results posted
• Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC)CompletedNCT02038647Phase 2Results posted
• Phase 3 Study to Evaluate the Acid-Inhibitory Effect of Multiple Oral Doses of Vonoprazan (TAK-438)CompletedNCT02037477Phase 3Results posted
• Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes MellitusCompletedNCT02024971Results posted
• Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)CompletedNCT02016183Results posted
• Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating DisorderCompletedNCT02009163Phase 3Results posted
• Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment"CompletedNCT02003014Results posted
• Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus"CompletedNCT02002975Results posted
• Voglibose Tablets 0.2 / OD Tablets 0.2 Special Drug Use Surveillance "Long-term Use in Patients With Impaired Glucose Tolerance"CompletedNCT01993927Results posted
• A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin LymphomaCompletedNCT01990534Phase 4Results posted
• Lansoprazole Tablets Special Drug Use Surveillance Gastroesophageal Reflux Disease With Dyspepsia SymptomsCompletedNCT01990339Results posted
• Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes MellitusCompletedNCT01990300Results posted
• Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult SubjectsCompletedNCT01989169Phase 1Results posted
• Evaluation of Different Dose Regimens of Aes-103 Given for 28 Days to Subjects With Stable Sickle Cell DiseaseTerminatedNCT01987908Phase 2Results posted
• Fasiglifam 25 mg BID vs 50 mg QDTerminatedNCT01982253Phase 2Results posted
• Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of VedolizumabCompletedNCT01981616Phase 1Results posted
• Effect of SSP-004184 (SPD602) on the Pharmacokinetics of Simvastatin in Healthy Adult SubjectsCompletedNCT01979185Phase 1Results posted
• Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral TherapyCompletedNCT01972724Phase 4Results posted
• Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With BiguanidesCompletedNCT01964976Results posted
• Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes MellitusCompletedNCT01964963Results posted
• Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With SulfonylureaCompletedNCT01964950Results posted
• Mass Balance, Pharmacokinetics and Metabolism Study of IXAZOMIBCompletedNCT01953783Phase 1Results posted
• A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding IntoleranceCompletedNCT01953081Phase 1/2Results posted
• A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel SyndromeCompletedNCT01952080Phase 3Results posted
• A Phase 1 Study in Patients With Relapsed or Refractory Hodgkin Lymphoma or Systemic Anaplastic Large Cell LymphomaCompletedNCT01950364Phase 1Results posted
• BAX 855 ContinuationCompletedNCT01945593Phase 3Results posted
• Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"CompletedNCT01945242Results posted
• Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"CompletedNCT01945216Results posted
• Phase 2 Study of Oral IXAZOMIB in Adult Participants With Relapsed and/or Refractory Follicular LymphomaCompletedNCT01939899Phase 2Results posted
• Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its OnsetTerminatedNCT01931566Phase 3Results posted
• Use of Tachosil® for Lymph Sealing During SurgeryCompletedNCT01920958Results posted
• Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced AngioedemaCompletedNCT01919801Phase 3Results posted
• Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test FormulationCompletedNCT01916304Phase 2Results posted
• Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical ProceduresCompletedNCT01913405Phase 3Results posted
• Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver DysfunctionCompletedNCT01912222Phase 1Results posted
• Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell LymphomaCompletedNCT01909934Phase 4Results posted
• The Effect of Food on the Bioavailability of a Single Dose of SSP-004184SS in Healthy Adult SubjectsCompletedNCT01905553Phase 1Results posted
• A Relative Bioavailability Study of SSP-004184AQ (Magnesium Salt) and SSP-004184SS (Disodium Salt)CompletedNCT01905540Phase 1Results posted
• A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic MalignanciesCompletedNCT01899053Phase 1Results posted
• Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's AtaxiaCompletedNCT01898884Phase 1Results posted
• Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or LymphomasCompletedNCT01898078Phase 1Results posted
• Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male AdultsCompletedNCT01892189Phase 1Results posted
• Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult VolunteersCompletedNCT01890785Phase 1Results posted
• Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 DiabetesCompletedNCT01890122Phase 3Results posted

← Takeda overview and focus areas